HK inno.N’s K-Cab (tegoprazan), a treatment for gastroesophageal reflux disease (GERD), is more effective in reducing night-time gastric acid than not only an existing proton pump inhibitor (PPI) but another potassium-competitive acid blocker (P-CAB), a study said.The company plans to use the study
“As a pharmaceutical company that makes drugs directly affecting Korean people’s health, we will walk on the right path with unwavering faith.”So said Korea United Pharm CEO Kang Duk-young at a group interview with health journalists where he evaluated the company’s performance last year and shared
Amid the slump of biopharmaceutical stocks, some companies have set out to buy back their shares, which analysts regard as a move to appease shareholders by stabilizing stock prices.For instance, Celltrion Healthcare, a comprehensive healthcare company, said Friday that it had decided on a buyback p
The American Society of Clinical Oncology (ASCO) updated adjuvant therapy guidelines in early lung cancer in five years, strongly recommending AstraZeneca’s EGFR tyrosine kinase inhibitor (TKI) Tagrisso (ingredient: osimertinib).On Tuesday, ASCO renewed the 2017 guideline on systemic adjuvant and ra
Yuhan Corp. recorded sluggish 2021 earnings, but the performance was rather a success given the base effect from licensing fee profits in 2020, analysts at investment banks said.On Wednesday, Yuhan posted a public filing as its sales and profit structures changed more than 30 percent. According to t
Opdivo (nivolumab), anti-PD-1 immunotherapy co-developed by Ono Pharmaceutical and BMS, added five indications for esophageal/gastroesophageal junction cancer, colorectal cancer, bladder cancer, renal cell cancer, and lung cancer in Korea.On Monday, the Ministry of Food and Drug Safety granted addit
Korean pharmaceutical and biotech companies are introducing a new standard for a compliance management system, ISO 37301, to enhance internal monitoring and prepare for ethical management of ESG (environmental, social, and corporate governance).Their move came mainly after the embezzlement case earl
Kukje Pharma said Thursday it rolled out Kukje Hyal Inj. (ingredient: sodium hyaluronate), treatment for knee arthritis and frozen shoulder.The treatment comes in a pre-filled syringe, administered to the intra-knee joint or shoulder joint for five consecutive weeks.The company said the product has
Pfizer, which dominated the global pneumococcal vaccine market with 13-valent Prevnar 13, said it won approval for a 20-valent vaccine in Europe.On Tuesday, the European Medicines Agency authorized the use of Apexxnar (brand name in the U.S.: Prevnar 20) for immunization and prevention of invasive d
Janssen’s Rybrevant (ingredient: amivantamab) obtained marketing approval for the treatment of non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations in Korea.On Tuesday, the Ministry of Food and Drug Safety (MFDS) approved Rybrevant to treat pati
Daewoong Pharmaceutical posted a record-high revenue in 2021 on the back of botulinum toxin export to the U.S. and a licensing-out deal over the nation’s 34th drug Fexuclue Tab. (fexuprazan hydrochloride), a treatment for gastroesophageal reflux disease (GERD). As a result, operating income jumped 4
Pfizer has changed the form of Ibrance (palbociclib), a CDK4/6 inhibitor, from capsules to tablets, making it easier for cancer patients to take the medication.The Ministry of Food and Drug Safety approved Ibrance Tab. 75 mg, 100 mg, and 125 mg on Monday.Ibrance is used as the standard treatment, al
A court dismissed local drugmakers’ appeal to nullify the government’s push to negotiate the recollection of health insurance coverage for choline alfoscerate (CA).The Ministry of Health and Welfare said the Seoul Administrative Court ruled in favor of the ministry on Friday.The ruling was against 2
SK Bioscience said Monday it signed a deal with the Pan American Health Organization to supply chickenpox vaccine to the Latin American market. It is the first time the company won bidding from PAHO, an international health agency under the United Nations.The Korean vaccine maker said it received PH
Amgen’s Lumakras (ingredient: sotorasib), the world’s first KRAS mutation inhibitor developed over 40 years, arrived in the Korean market.The treatment is indicated for non-small cell lung cancer (NSCLC). However, as it recently showed anticancer effects in pancreatic cancer, the marketing approval
The nation is experiencing a shortage of acetaminophen-containing cold medicines amid the surge of the Omicron variant and increased at-home treatment.Local pharmaceutical companies have begun running an emergency production system to cope with the shortage of such drugs.On Monday last week, the gov
HK inno.N and AbClon said they would work together to develop and commercialize CAR-T therapy, and their collaboration will continue through a contract development manufacturing organization (CDMO) deal.On Monday, the two signed a memorandum of understanding for the joint development of AT-101, a ty
Korean pharmaceutical companies recently obtained marketing approval for generic drugs of MSD’s Bridion (sugammadex), a muscle relaxation antagonist.As the original drug’s patent expires in April, local drugmakers are expected to engage in fierce competition to sell generic copies, observers said.Th
Medpacto said that it has signed a business agreement with HITS, specializing in artificial intelligence-based drug development.Under the accord, the two companies will jointly secure and share technology and experimental data for new drug development, establish new business models and projects for
inno. N said that the Ministry of Food and Drug Safety has approved K-CAB orally disintegrating tablet (ODT) 50mg, a gastroesophageal reflux therapy.The company plans to launch the new K-CAB formulation in the first half of this year, further spurring its share in the Korean peptic ulcer solvent mar